Alan Howe Yee, D.O.
Associate Clinical Professor
Neurology Associate Program Director
To see if Alan Howe Yee is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
Additional Numbers
Physician Referrals
Philosophy of Care
I believe optimal patient care can be achieved with mutual trust, diligence, combined with service excellence and expertise. Respect for others and humility have allowed me to learn from colleagues and importantly, from patients. Daily collaboration with nurses and physician specialists provide a comprehensive approach to high-quality patient care. I emphasize active communication between patients, families, and colleagues to ensure up-to-date information is conveyed effectively.
Clinical Interests
Dr. Alan Yee is a fellowship-trained Critical Care Neurologist offering specialty care to adults with stroke, cerebrovascular, and critical brain disease.
Research/Academic Interests
Dr. Yee's scholarship interests focus on medical education and research related to acute and emergency neurology. His prior work focused on improving neurological prognostication in patients with critical brain disease.
Division
Neurology
Undergraduate School
B.S., San Francisco State University, San Francisco CA 2000
Medical School
D.O., Kansas City University of Medicine and Biosciences-College of Osteopathic Medicine, Kansas City MO 2004
Internship
Internal Medicine, Cleveland Clinic Foundation, Cleveland OH 2004-2005
Residency
Internal Medicine, Cleveland Clinic Foundation, Cleveland OH 2005-2007
Residency
Neurology, The Mayo Clinic, Rochester MN 2007-2010
Fellowship
Neurology/Neurocritical Care, UC San Francisco Medical Center, San Francisco CA 2010-2012
UC Davis Interprofessional Teaching Scholars Program; Teaching Scholar, 2018, 2019, 2020
Neurology Clerkship Preceptor of the Year - Geisel School of Medicine at Dartmouth, 2017
Mayo Clinic Young Investigator Research Symposium - best research poster presentation competition (1st Place). Title: Factors Influencing Time to Death After Withdrawal of Life Support in Neurocritical Patients, 2010
Mayo Clinic Neurology Residency - 2009 American Academy of Neurology Annual Meeting Resident Scholarship Award, 2008
Student D.O. of the Year Award- Kansas City University of Medicine and Biosciences- College of Osteopathic Medicine, 2004
Henry Holloway, D.O. Award - Kansas City University of Medicine and Biosciences - College of Osteopathic Medicine, 2004
Physicians' Hall of Sponsors Scholarship - Kansas City University of Medicine and Biosciences - College of Osteopathic Medicine, 2003
Murray NM, Ke M, Yee A, Chen C, Wong C, Bedenk A, Fernandes J, Barazangi N, Tong D. ICU Interventions in Ischemic Stroke Patients Treated Using Liberalized IV-tPA Criteria. J Stroke Cerebrovasc Dis. 2019 Sep;28(9):2488-2495. doi:10.1016/j.jstrokecerebrovasdis.2019.06.015. Epub 2019 Jul 3. PMID:31277995.
Durocher M, Ander BP, Jickling G, Hamade F, Hull H, Knepp B, Liu DZ, Zhan X, Tran A, Cheng X, Ng K, Yee A, Sharp FR, Stamova B. Inflammatory, regulatory, and autophagy co-expression modules and hub genes underlie the peripheral immune response to human intracerebral hemorrhage. J Neuroinflammation. 2019 Mar 5;16(1):56. doi:10.1186/s12974-019-1433-4. PMID:30836997.
Hoffman SJ, Yee AH, Slusser JP, Rihal CS, Holmes DR Jr, Rabinstein AA, Gulati R. Neuroimaging patterns of ischemic stroke after percutaneous coronary intervention. Catheter Cardiovasc Interv. 2015 May;85(6):1033-40. doi:10.1002/ccd.25678. Epub 2014 Oct 7. PMID:25256948.
Sheth SA, Yee AH. Mystery case: an unexpected complication of IV thrombolysis for acute ischemic stroke. Neurology. 2013 Aug 13;81(7):e42-3. doi:10.1212/WNL.0b013e3182a08d7f. PMID:23940024.
Meisel K, Yee A, Stout C, Kim W, Cooke D, Halbach V. Arteriovenous fistula after ventriculostomy in aneurysmal subarachnoid hemorrhage. Neurology. 2013 Jun 4;80(23):2168. doi:10.1212/WNL.0b013e318295d66f. PMID:23733553.
Kamel H, Navi BB, Elijovich L, Josephson SA, Yee AH, Fung G, Johnston SC, Smith WS. Pilot randomized trial of outpatient cardiac monitoring after cryptogenic stroke. Stroke. 2013 Feb;44(2):528-30. doi:10.1161/STROKEAHA.112.679100. Epub 2012 Nov 27. PMID:23192756.
Rabinstein AA, Yee AH, Mandrekar J, Fugate JE, de Groot YJ, Kompanje EJ, Shutter LA, Freeman WD, Rubin MA, Wijdicks EF. Prediction of potential for organ donation after cardiac death in patients in neurocritical state: a prospective observational study. Lancet Neurol. 2012 May;11(5):414-9. doi:10.1016/S1474-4422(12)70060-1. Epub 2012 Apr 10. PMID:22494955.
Yee AH, Mandrekar J, Rabinstein AA, Wijdicks EF. Predictors of apnea test failure during brain death determination. Neurocrit Care. 2010 Jun;12(3):352-5. doi:10.1007/s12028-010-9343-4. PMID:20217276.
Yee AH, Rabinstein AA, Thapa P, Mandrekar J, Wijdicks EF. Factors influencing time to death after withdrawal of life support in neurocritical patients. Neurology. 2010 Apr 27;74(17):1380-5. doi:10.1212/WNL.0b013e3181dad5f0. PMID:20421582.
Yee AH, Rabinstein AA. Neurologic presentations of acid-base imbalance, electrolyte abnormalities, and endocrine emergencies. Neurol Clin. 2010 Feb;28(1):1-16. doi:10.1016/j.ncl.2009.09.002. PMID:19932372.